1. Home
  2. ARTW vs PHIO Comparison

ARTW vs PHIO Comparison

Compare ARTW & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

HOLD

Current Price

$2.48

Market Cap

13.4M

Sector

Industrials

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.08

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTW
PHIO
Founded
1956
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
11.2M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
ARTW
PHIO
Price
$2.48
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
8.9K
127.6K
Earning Date
04-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
N/A
EPS
0.04
N/A
Revenue
$22,975,408.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$64.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.04
$0.81
52 Week High
$4.69
$4.19

Technical Indicators

Market Signals
Indicator
ARTW
PHIO
Relative Strength Index (RSI) 40.65 54.97
Support Level $2.07 $1.06
Resistance Level $2.52 $1.15
Average True Range (ATR) 0.11 0.05
MACD -0.01 0.01
Stochastic Oscillator 16.67 72.76

Price Performance

Historical Comparison
ARTW
PHIO

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: